Document is current
Any future updates will be listed below
-
Authors
Liu, Qi https://orcid.org/0000-0003-4008-2226
Nguyen, Tram N. B. https://orcid.org/0000-0001-6728-5563
Tobe, Russell H. https://orcid.org/0000-0002-7738-8344
Stern, Emily R.
Ely, Benjamin A.
Gabbay, Vilma https://orcid.org/0000-0001-8819-5137
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute on Drug Abuse (F30DA056227)
U.S. Department of Health & Human Services | NIH | National Institute on Drug Abuse (R01DA054885)
U.S. Department of Health & Human Services | NIH | National Institute on Drug Abuse (R01DA059527)
U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences (T32GM149364)
U.S. Department of Health & Human Services | NIH | National Center for Advancing Translational Sciences (T32TR004537)
U.S. Department of Health & Human Services | NIH | National Institute of Mental Health (R01MH126981)
U.S. Department of Health & Human Services | NIH | National Institute of Mental Health (R01MH120601)
U.S. Department of Health & Human Services | NIH | National Institute of Mental Health (R01MH131207)
U.S. Department of Health & Human Services | NIH | National Institute of Mental Health (R01MH128878)
U.S. Department of Health & Human Services | NIH | National Institute of Mental Health (R01MH126821)
- License Information
-
More Information
Article History
Received: 14 July 2025
Revised: 17 March 2026
Accepted: 30 March 2026
First Online: 23 April 2026
Competing interests
: Dr. Russell Tobe reported receiving grant support from Axial Therapeutics, F Hoffmann-La Roche, Intra-Cellular Therapies, Janssen Research & Development, and MapLight Therapeutics and attending advisory boards for F Hoffmann-La Roche outside the submitted work. All other authors report no biomedical financial interests or potential conflicts of interest.
